Clinical Trials
3 trialsNCT06992258 2026-03-17
FRUITION
Criterium, Inc.
Phase 2 Recruiting
NCT02743221 2024-08-20
TASCO1
Servier
Phase 2 Completed
NCT04854434 2023-11-03
A Study to Evaluate the Safety and Efficacy of Selinexor With or Without Pembrolizumab Versus Standard of Care in Previously Treated Metastatic Colorectal Cancer With RAS Mutations
Karyopharm Therapeutics Inc
Phase 2 Terminated